Publications by authors named "Pedro H Farina"
JTO Clin Res Rep
October 2022
Article Synopsis
- Advances in comprehensive genomic profiling (CGP) for lung adenocarcinomas (LUADs) lead to personalized treatment, and a study investigated Brazilian oncologists' attitudes toward CGP when funding is available.
- An online survey assessed oncologists' confidence in interpreting CGP results, treating oncogenic-driven LUAD, and managing tyrosine kinase inhibitor side effects; 67% of respondents felt confident across all areas.
- Despite funding, only 51% of oncologists routinely request CGP for stage IV LUAD, with confidence linked to their willingness to request CGP; challenges include long turnaround times and concerns about treatment delays.
